The role of natriuretic peptide estimation in severe COVID-19

Submitted: April 15, 2020
Accepted: April 22, 2020
Published: April 27, 2020
Abstract Views: 1334
PDF: 1000
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Since its inception in Wuhan in December 2019, Coronavirus disease 2019 (COVID-19) has shattered the economies and health-care infrastructures worldwide. Even the best of health-care systems (United States, Italy) have been overwhelmed and collapsed because of this unprecedented pandemic. India is preparing itself for the onslaught of Coronavirus. After recording its first case on January 30th, 2020, the rise was slow until the last week of March. However, since then, the number of cases has increased exponentially, and as on April 14th, 2020, there have been more than 10,000 cases of coronavirus disease (COVID-19) in India, which has resulted in more than 350 deaths.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Prakash Negi, Indira Gandhi Government Medical College

Professor

Department of Cardiology

How to Cite

Mahajan, Kunal, and Prakash Negi. 2020. “The Role of Natriuretic Peptide Estimation in Severe COVID-19”. Monaldi Archives for Chest Disease 90 (2). https://doi.org/10.4081/monaldi.2020.1316.